featured
Outcomes of Conversion to Faricimab After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Oedema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema
Br J Ophthalmol 2024 Aug 22;108(9)1257-1262, AF Durrani, B Momenaei, T Wakabayashi, S Vemula, SA Pandit, J Hsu, AC Ho, MJ Spirn, MA Klufas, SJ Garg, JF Vander, CD Regillo, A Chiang, AE Kuriyan, Y YonekawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.